缬沙坦治疗老年高血压伴糖耐量异常患者的疗效

目的：探讨缬沙坦治疗老年高血压伴糖耐量异常患者的疗效。方法方便选取2013年8月―2016年1月该院收治的86例老年高血压伴糖耐量异常患者作为研究对象,按照数字法分为参照组(n=43,采用氨氯地平治疗﹚和试验组(n=43,采用缬沙坦治疗﹚,比较2组患者的夜间血压、糖耐量、NO水平、血糖、血压达标情况。结果经统计分析,试验组43例患者的夜间血压(收缩压和舒张压﹚(121.13±7.34)mmHg、(76.62±8.25)mmHg较参照组更胜一筹,糖耐量、NO水平、血糖达标率和血压达标率均优于参照组,组间差异有统计学意义(P<0.05﹚。结论缬沙坦治疗老年高血压伴糖耐量异常患者疗效优于氨氯地平,可达到理想的整体达标率,值得临床借鉴和全面推广。

The Efficacy of Valsartan in Elderly Hypertensive Patients with Impaired Glucose Tolerance

Objective To observe the effect of valsartan on hypertension associated with impaired glucose tolerance in el-derly patients. Methods Convenient selection in August 2013―January 2016 in our hospital 86 cases of elderly patients with hypertension and impaired glucose tolerance was observed as the target, according to figures divided into reference group(n =43, using amlodipine) and test group(n =43, the use of valsartan), the indexes of two groups of elderly hyperten-sion patients with impaired glucose tolerance were compared. Results After statistical analysis, the test group of 43 cases of patients with nocturnal blood pressure (systolic and diastolic blood pressure) (1.2113 ± 7.34)mmHg, (76.62 ± 8.25)mmHg with the reference group superior, glucose tolerance, NO levels, blood glucose and blood pressure in the test group were bet-ter than those of the reference group in 43 cases,significant differences between the groups (P<0.05). Conclusion Valsartan in elderly hypertensive patients with impaired glucose tolerance more effective than amlodipine, can achieve the desired overall compliance rate is worthy of reference and comprehensive promotion.